Executive Summary
Overnight SEC filings for January 16, 2026, feature a cluster of financial results disclosures from major banks (M&T Bank, Regions Financial, PNC, State Street) signaling pre-market earnings season kickoff with neutral sentiment due to undisclosed metrics. Bearish outliers include delisting notices from Autonomix Medical and GRI Bio, plus material impairments at BCB Bancorp, highlighting small-cap distress amid broader neutral themes of material agreements, officer changes, and equity issuances across sectors. Cumulative patterns suggest financing pressures and governance shifts in industrials, biotech, and financials, with limited details tempering immediate market impact but warranting vigilance for alpha in distressed plays.
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from January 14, 2026.
Investment Signals(4)
- Autonomix Medical↓(BEARISH)▲
Notice of delisting or failure to satisfy listing standards indicates severe compliance risks
- GRI Bio↓(BEARISH)▲
Delisting notice signals potential liquidity crisis and shareholder value erosion
- BCB Bancorp↓(BEARISH)▲
Disclosure of material impairments points to asset write-downs and earnings pressure
- FedEx Corp (FDX)↓(BULLISH)▲
Entry into material agreement and financial obligation may enhance operations if strategic
Risk Flags(4)
High materiality delisting risk threatens trading liquidity and investor confidence
Failure to meet listing standards raises systemic small-cap governance concerns
Material asset impairments undisclosed in scale amplify balance sheet vulnerabilities
Creation of off-balance sheet arrangements without terms heightens debt exposure
Opportunities(3)
Potential operational or financing deal could drive efficiency gains in logistics sector
Undisclosed partnership may unlock strategic growth in chemicals
Completion of acquisition offers pipeline expansion potential in biotech
Sector Themes(3)
- Banking Pre-Earnings Wave◆
M&T, Regions, PNC, State Street filings cluster signals sector rotation opportunities ahead of Q4 results, monitor for NIM trends
- Small-Cap Distress Signals◆
Delistings (Autonomix, GRI Bio) and impairments (BCB) correlate with equity dilutions, implying broad microcap weakness and short opportunities
- Financing & Restructuring Surge◆
Multiple material agreements (FedEx, Chemours, NightFood) and officer changes indicate capital raises amid economic uncertainty
Watch List(4)
Financial results filing; track AUM, fee income for asset management trends
Earnings disclosures; assess loan loss provisions amid rate environment
- Autonomix Medical & GRI Bio👁
Delisting developments; potential for OTC transfer or bankruptcy
Full details on material agreement and officer changes for logistics M&A insights
Filing Analyses(41)
16-01-2026
FedEx Corp filed a Form 8-K on January 16, 2026 (AccNo: 0001104659-26-004325, Size: 1 MB), reporting multiple items: Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific details on transaction value, parties, financial impacts, or named entities provided in the available summary. Critical details such as dollar amounts, share counts, or strategic context are NOT_DISCLOSED.
16-01-2026
Topgolf Callaway Brands Corp. filed a Form 8-K on January 16, 2026 (AccNo: 0001193125-26-014581, Size: 480 KB), reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws, or a change in fiscal year. Item 9.01 includes financial statements and exhibits. No specific details on the amendments, changes, transaction values, or financial metrics are disclosed.
16-01-2026
Uniti Group Inc. filed a Form 8-K on January 16, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Accession number: 0000950103-26-000585. File size: 235 KB. No specific details on the events, transactions, or exhibits are disclosed in the provided filing summary.
16-01-2026
M&T BANK CORP filed a Form 8-K on January 16, 2026 (AccNo: 0000036270-26-000004, Size: 6 MB), disclosing Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing for financial results. No specific financial metrics, transaction values, or other quantitative details are provided in the filing summary.
16-01-2026
Data Storage Corp filed a Form 8-K on January 16, 2026 (AccNo: 0001731122-26-000067, Size: 262 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
16-01-2026
Tvardi Therapeutics, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001104659-26-004273, Size: 7 MB) under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure with no specific event details, transaction values, or financial metrics provided in the summary. Sector is not specified.
16-01-2026
Advanced Flower Capital Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001628280-26-002263), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement, and Item 9.01 Financial Statements and Exhibits. No specific transaction details, dollar values, counterparties, or financial metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.
16-01-2026
Incannex Healthcare Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001213900-26-004866, size: 198 KB), reporting under Item 5.07 the submission of matters to a vote of security holders. No specific details on proposals, vote outcomes, or results are disclosed in the provided filing summary. This is a standard disclosure for shareholder meeting votes.
16-01-2026
SemiLEDs Corp filed a Form 8-K on January 16, 2026 (AccNo: 0001193125-26-014502, Size: 237 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.
16-01-2026
Qnity Electronics, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0002058873-26-000002, Size: 235 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). Specific details including the key position affected, individual names, appointment or resignation status, reasons, or financial metrics are NOT_DISCLOSED. Sector is not specified.
16-01-2026
News Corp filed a Form 8-K on January 16, 2026 (AccNo: 0001564708-26-000011, Size: 400 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are provided in the filing summary. All quantitative financial data, named entities beyond the company, and event specifics are NOT_DISCLOSED.
16-01-2026
Regions Financial Corp filed a Form 8-K on January 16, 2026 (AccNo: 0001281761-26-000006, Size: 11 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results. No specific numerical data, transaction details, or financial metrics are provided in the filing summary.
16-01-2026
Planet Labs PBC filed a Form 8-K on January 16, 2026 (AccNo: 0001193125-26-014326, Size: 192 KB), reporting Items 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), and 8.01 (Other Events). This is a multi-item mandatory disclosure with no specific transaction details, dollar values, share counts, or other numerical data disclosed. Sector not specified.
16-01-2026
DynaResource, Inc. filed a General Filing on January 16, 2026, reporting under Item 9.01 Financial Statements and Exhibits. The filing has Accession Number 0001193125-26-014293 and a file size of 984 KB. No details on the specific financial statements, exhibits, or any material events are provided in the summary.
16-01-2026
Rekor Systems, Inc. filed an 8-K on January 16, 2026 (AccNo: 0001437749-26-001375, Size: 155 KB) disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons, or quantitative data are provided in the filing summary. Sector is not specified.
16-01-2026
The company filed a Form 8-K on January 16, 2026 (AccNo: 0001628280-26-002237, size 143 KB) under Item 3.02 disclosing unregistered sales of equity securities. No specific transaction details, dollar values, share counts, parties involved, or financial impacts are provided in the filing summary. This is a general filing categorized as Event Type: General Filing from source us_sec, with sector not specified.
16-01-2026
Primo Brands Corp filed a Form 8-K on January 16, 2026 (AccNo: 0001193125-26-014611), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on the affected position, individual names, appointment/resignation nature, reasons, or quantitative data are provided in the filing summary. Sector is not specified.
16-01-2026
PNC Financial Services Group, Inc. filed an 8-K on January 16, 2026 (AccNo: 0000713676-26-000006, Size: 3 MB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results but no specific revenue, earnings, transaction values, or quantitative metrics are mentioned in the provided filing summary. Event classified as Financial Results from US SEC source.
16-01-2026
Chemours Co filed a Form 8-K on January 16, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing for material events. No details on the agreement, transaction value, financial impacts, or other specifics are disclosed in the provided summary.
16-01-2026
Mosaic Co (MOSAIC CO) filed a Form 8-K on January 16, 2026 (AccNo: 0001285785-26-000007, Size: 188 KB), reporting solely under Item 9.01 Financial Statements and Exhibits. No details on specific financial statements, exhibits, or core events are provided in the filing summary. Sector not specified.
16-01-2026
Getty Images Holdings, Inc. filed a Form 8-K on January 16, 2026, under Item 8.01 Other Events. Accession number: 0001213900-26-004889. File size: 202 KB. No specific details on the event, transaction, or financial impacts are disclosed.
16-01-2026
SES AI Corp filed a Form 8-K on January 16, 2026 (AccNo: 0001819142-26-000003, Size: 9 MB) under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific details on the disclosed information, events, transactions, or financial metrics are provided in the filing summary. Sector not specified.
16-01-2026
State Street Corp filed an 8-K on January 16, 2026 (AccNo: 0000093751-26-000008, size 9 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a financial results announcement from the US market. No specific financial metrics, transaction values, or quantitative data disclosed in the provided filing summary.
16-01-2026
Arbutus Biopharma Corp filed a Form 8-K on January 16, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, financial statements, or exhibits are disclosed in the provided filing summary. All transaction values, financial metrics, and other quantitative data are NOT_DISCLOSED.
16-01-2026
Autonomix Medical, Inc. filed a Form 8-K on 2026-01-16 (AccNo: 0001437749-26-001381, Size: 169 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on the delisting reason, transaction values, financial impacts, or related entities are disclosed. Sector is not specified.
16-01-2026
Ondas Holdings Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001213900-26-004897), disclosing Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and Item 9.01 (Financial Statements and Exhibits). No specific details on affected positions, individuals, reasons for changes, or governance impacts are provided. No quantitative data, names, or further facts are mentioned.
16-01-2026
QHSLab, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001493152-26-002496, Size: 231 KB) reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Sector not specified. No details on core event, transaction, or financials disclosed in the provided filing summary.
16-01-2026
Hoth Therapeutics, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001213900-26-004899, size 9 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
16-01-2026
Hillenbrand, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001104659-26-004328), reporting under Item 2.02 Results of Operations and Financial Condition. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.
16-01-2026
GRI Bio, Inc. filed an 8-K on January 16, 2026 (AccNo: 0001824293-26-000011, Size: 167 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional details on the delisting reasons, financial impacts, or transaction values are provided. Sector is not specified.
16-01-2026
ITHAX Acquisition Corp III filed an 8-K on January 16, 2026 (AccNo: 0001104659-26-004327), disclosing a merger/acquisition under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on deal structure, parties involved, valuation, consideration, or strategic rationale are provided in the filing summary. Sector is not specified.
16-01-2026
Agenus Inc. filed an 8-K on January 16, 2026 (AccNo: 0001193125-26-014678, Size: 788 KB) announcing completion of an acquisition or disposition of assets under Item 2.01 and unregistered sales of equity securities under Item 3.02. The filing includes Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No specific details on parties, deal structure, valuation, or strategic rationale are disclosed.
16-01-2026
Allegro MicroSystems, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001193125-26-014666, Size: 163 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure with no core event, transaction details, or quantitative data explicitly stated. All financial metrics, impacts, and specifics are NOT_DISCLOSED.
16-01-2026
NightFood Holdings, Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001493152-26-002499, Size: 755 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, sales, transaction values, or financial impacts disclosed in the provided summary. Sector not specified.
16-01-2026
TransDigm Group INC filed a Form 8-K on January 16, 2026 (AccNo: 0001260221-26-000002, Size: 399 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events, financial statements, exhibits, transaction values, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.
16-01-2026
Murphy USA Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001573516-26-000011, Size: 579 KB), disclosing an officer change under Item 5.02 covering departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or quantitative data such as transaction values or share counts are disclosed.
16-01-2026
Ondas Holdings Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001213900-26-004902, Size: 213 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This constitutes a financial results disclosure event from the US market. No specific financial metrics, transaction details, or sector information are provided in the filing summary.
16-01-2026
BCB Bancorp Inc. filed a Form 8-K on January 16, 2026 (AccNo: 0001193125-26-014695), reporting under Item 2.06 Material Impairments. No details on the nature, dollar value, or financial impact of the impairments are provided in the summary. This disclosure indicates a material negative event for the company.
16-01-2026
Nukkleus Inc. filed an 8-K on January 16, 2026 (AccNo: 0001213900-26-004905, Size: 474 KB) announcing entry into a material definitive agreement (Item 1.01), completion of acquisition or disposition of assets (Item 2.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on deal structure, parties involved, valuation, strategic rationale, and financial impacts are NOT_DISCLOSED in the provided filing summary. Sector is not specified.
16-01-2026
Bassett Furniture Industries Inc filed a Form 8-K on January 16, 2026 (AccNo: 0001437749-26-001385, Size: 177 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other event, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
16-01-2026
STAAR SURGICAL CO filed a Form 8-K on January 16, 2026 (AccNo: 0001193125-26-014681, size 172 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, reason, or terms are provided. Sector is not specified.
Get daily alerts with 4 investment signals, 4 risk alerts, 3 opportunities and full AI analysis of all 41 filings
🇺🇸 More from United States
View all →March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings